Literature DB >> 6352210

Importance of timing of preprandial subcutaneous insulin administration in the management of diabetes mellitus.

G D Dimitriadis, J E Gerich.   

Abstract

Since little is known regarding the appropriate time for preprandial insulin administration, we compared the effects of 30-min subcutaneous insulin infusions started 60 min, 30 min, and immediately before meal ingestion on postprandial plasma glucose and insulin profiles in eight subjects with insulin-dependent diabetes mellitus. Of these three regimens, administration of insulin 60 min before meal ingestion provided plasma glucose and insulin profiles closest to normal and permitted less insulin to be used. Our results suggest that adjustments in the timing as well as in the amount of insulin administered preprandially may be used in the management of diabetes and that prolonging the interval between administration of insulin and meal ingestion may reduce insulin requirements and thus decrease the hyperinsulinemia usually associated with insulin therapy.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6352210     DOI: 10.2337/diacare.6.4.374

Source DB:  PubMed          Journal:  Diabetes Care        ISSN: 0149-5992            Impact factor:   19.112


  17 in total

Review 1.  Recent developments in insulin delivery techniques. Current status and future potential.

Authors:  F P Kennedy
Journal:  Drugs       Date:  1991-08       Impact factor: 9.546

Review 2.  What are the best options for controlling prandial glycemia?

Authors:  Stephen Clement
Journal:  Curr Diab Rep       Date:  2009-10       Impact factor: 4.810

Review 3.  Clinical pharmacokinetics and pharmacodynamics of insulin lispro mixtures.

Authors:  Paris Roach; James R Woodworth
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

Review 4.  How to achieve optimal diabetic control in patients with insulin-dependent diabetes.

Authors:  S R Page; R B Tattersall
Journal:  Postgrad Med J       Date:  1994-10       Impact factor: 2.401

5.  Long-term intensive insulin therapy in IDDM: effects on HbA1c, risk for severe and mild hypoglycaemia, status of counterregulation and awareness of hypoglycaemia.

Authors:  S Pampanelli; C Fanelli; C Lalli; M Ciofetta; P D Sindaco; M Lepore; F Modarelli; A M Rambotti; L Epifano; A Di Vincenzo; L Bartocci; B Annibale; P Brunetti; G B Bolli
Journal:  Diabetologia       Date:  1996-06       Impact factor: 10.122

Review 6.  Pharmacokinetics of insulin. Implications for continuous subcutaneous insulin infusion therapy.

Authors:  E W Kraegen; D J Chisholm
Journal:  Clin Pharmacokinet       Date:  1985 Jul-Aug       Impact factor: 6.447

Review 7.  New aspects of insulin therapy in type 1 and type 2 diabetes.

Authors:  D G Dills
Journal:  Curr Diab Rep       Date:  2001-10       Impact factor: 4.810

8.  Effects of two new alpha-glucosidase inhibitors on glycemic control in patients with insulin-dependent diabetes mellitus.

Authors:  G Dimitriadis; S Raptis; A Raptis; E Hatziagelaki; A Mitrakou; P Halvatsiotis; S Ladas; I Hillebrand
Journal:  Klin Wochenschr       Date:  1986-05-02

9.  Pharmacokinetic and pharmacodynamic properties of insulin aspart and human insulin.

Authors:  Ole Østerberg; Lars Erichsen; Steen H Ingwersen; Anne Plum; Henrik E Poulsen; Paolo Vicini
Journal:  J Pharmacokinet Pharmacodyn       Date:  2003-06       Impact factor: 2.745

Review 10.  Management of insulin-dependent diabetes mellitus.

Authors:  D M Nathan
Journal:  Drugs       Date:  1992       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.